NCT00161304View on ClinicalTrials.gov

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2004

Study Completion Date

November 30, 2004

Conditions

Men With Low Testosterone Levels

Interventions

DRUG

Testosterone Enanthate

Testosterone Enanthate

OTHER

Placebo

placebo

Trial Locations (1)

90232

Urological Sciences Research Foundation, Culver City

Sponsors

Collaborators (1)

Watson Pharmaceuticals

All Listed Sponsors

collaborator

Solvay Pharmaceuticals

INDUSTRY

collaborator

Watson Pharmaceuticals

INDUSTRY

lead

Leonard S. Marks, M.D.

OTHER

NCT00161304 - Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency | Biotech Hunter | Biotech Hunter